176 related articles for article (PubMed ID: 22669594)
1. Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins.
Kumar N; Shishu ; Bansal G; Kumar S; Jana AK
AAPS PharmSciTech; 2012 Sep; 13(3):863-74. PubMed ID: 22669594
[TBL] [Abstract][Full Text] [Related]
2. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt.
Kumar N; Shishu ; Bansal G; Kumar S; Jana AK
Drug Dev Ind Pharm; 2013 Feb; 39(2):342-51. PubMed ID: 22553909
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product.
Alsarra IA; Alanazi FK; Ahmed SM; Bosela AA; Alhamed SS; Mowafy HA; Neau SH
Arch Pharm Res; 2010 Jul; 33(7):1009-17. PubMed ID: 20661710
[TBL] [Abstract][Full Text] [Related]
4. Hot-melt extrusion as a continuous manufacturing process to form ternary cyclodextrin inclusion complexes.
Thiry J; Krier F; Ratwatte S; Thomassin JM; Jerome C; Evrard B
Eur J Pharm Sci; 2017 Jan; 96():590-597. PubMed ID: 27687637
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
Taupitz T; Dressman JB; Buchanan CM; Klein S
Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
[TBL] [Abstract][Full Text] [Related]
7. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
Tao T; Zhao Y; Wu J; Zhou B
Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
[TBL] [Abstract][Full Text] [Related]
9. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.
Karashima M; Sano N; Yamamoto S; Arai Y; Yamamoto K; Amano N; Ikeda Y
Eur J Pharm Biopharm; 2017 Jun; 115():65-72. PubMed ID: 28223260
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
11. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
14. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
[TBL] [Abstract][Full Text] [Related]
15. When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media.
Cuoco A; Eriksen JB; Luppi B; Brandl M; Bauer-Brandl A
J Pharm Sci; 2023 May; 112(5):1372-1378. PubMed ID: 36539063
[TBL] [Abstract][Full Text] [Related]
16. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
18. Development of stabilized itraconazole nanodispersions by using high-gravity technique.
Zhang ZL; Le Y; Wang JX; Zhao H; Chen JF
Drug Dev Ind Pharm; 2012 Dec; 38(12):1512-20. PubMed ID: 22435399
[TBL] [Abstract][Full Text] [Related]
19. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
20. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.
Alhowyan AA; Altamimi MA; Kalam MA; Khan AA; Badran M; Binkhathlan Z; Alkholief M; Alshamsan A
J Microbiol Methods; 2019 Jun; 161():87-95. PubMed ID: 30738109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
